Lira, Uganda | URN | The Ministry of Health has launched the use of Lenacapavir, a revolutionary Pre-Exposure Prophylaxis long-acting injectable drug for HIV prevention in Uganda. The National Launch, which took place at Lira Regional Referral Hospital, was presided over by Dr. Jane Ruth Aceng Ocero, the Minister of …
Read More »
Kampala, Uganda | URN | The Ministry of Health will, on Friday, roll out the countrywide use of Lenacapavir injection at Lira Regional Referral Hospital. In July last year, the World Health Organization (WHO) released guidelines recommending the use of injectable lenacapvir(LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) …
Read More »
Kampala, Uganda | THE INDEPENDENT | An initial consignment of 19, 200 doses of Lanacapavir, a six-monthly HIV prevention injection drug, has arrived in Uganda, marking a major milestone in the country’s HIV prevention efforts. The arrival of the consignment donated by the Global Fund follows approval of the drug for …
Read More »
Drug can be used to prevent catching the virus and treat those who have it Kampala, Uganda | THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and key HIV/AIDS prevention …
Read More »
Lenacapavir, trialed in Uganda, offers 100% protection but will it reach those who need it most? Kampala, Uganda | RONALD MUSOKE | Thanks to a landmark deal announced on July 9 by the Global Fund, Uganda is expected to be among the first countries in sub-Saharan Africa to get access to …
Read More »
Kampala, Uganda | THE INDEPENDENT | The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has announced that it has signed an access agreement with Pharmaceutical Company Gilead Sciences to procure lenacapavir, a long-acting injectable for HIV prevention, for low- and middle-income countries (LMICs). This development, which …
Read More »
Kampala, Uganda | THE INDEPENDENT | USAID has been present in Uganda for over sixty years. It has funded development in agriculture, education and research in HIV/AIDS among others. USAID had a very significant impact of HIV/AID prevention and treatment efforts through PEPFAR. Specifically for HIV, at a time when …
Read More »
GENEVA, Switzerland | THE INDEPENDENT | The United States Food and Drug Administration (FDA) has approved long-acting injectable lenacapavir for HIV prevention. The new medicine is administered by injection once every 6 months and is a significant step in improving prevention options for people at risk of HIV infection around the …
Read More »
Johannesberg, South Africa | THE INDEPENDENT | Food and Drug Administration (FDA) approval of injectable lenacapavir (LEN) for the prevention of HIV as pre-exposure prophylaxis (PrEP). LEN, developed by Gilead Sciences, is a twice-yearly injectable PrEP option that showed nearly complete protection against HIV in the landmark PURPOSE 1 and 2 …
Read More »
SPECIAL REPORT | THE INDEPENDENT | Philanthropist Bill Gates, the founder and co-chair of the Bill and Melinda Gates Foundation says more lives can be saved from HIV if modern HIV prevention tools can be spread out. The Bill and Melinda Gates Foundation has been one of the biggest funder to …
Read More »
The Independent Uganda: You get the Truth we Pay the Price
